Transfer of manualized CBT for social phobia into clinical practice (SOPHO-PRAX): a study protocol for a cluster-randomized controlled trial

Stephen Crawcour, Eric Leibing, Denise Ginzburg, Ulrich Stangier, Jörg Wiltink, Jürgen Hoyer, Stephen Crawcour, Eric Leibing, Denise Ginzburg, Ulrich Stangier, Jörg Wiltink, Jürgen Hoyer

Abstract

Background: Cognitive-behavioral therapy (CBT) is generally known to be efficacious in the treatment of social phobia when applied in RCTs, namely when the treatment manual is based on the Clark-Wells approach. However, little is known about the efficacy of manualized treatments in routine clinical practice (Phase IV of psychotherapy research). The present study (SOPHO-PRAX) is a continuation of a large multicenter randomized clinical trial (SOPHO-NET) and analyzes the extent to which additional training practitioners in manualized procedures enhances treatment effect.

Methods/design: Thirty-six private practitioners will be included in three treatment centers and randomly designated to either training in manualized CBT or no specific training. The treatment effects of the therapies conducted by both groups of therapists will be compared. A total of 162 patients (n=116 completers; n=58 per condition) will be enrolled. Liebowitz Social Anxiety Scale (LSAS) will serve as primary outcome measure. Remission from social phobia is defined as LSAS total ≤ 30 points. Data will be collected at treatment begin, after 8, 15, and 25 sessions (50 min each), at treatment completion, as well at 6 and 12 months post-treatment.

Discussion: The present CBT trial combines elements of randomized controlled trials and naturalistic studies in an innovative way. It will directly inform about the incremental effects of procedures established in a controlled trial into clinical practice. Study results are relevant to healthcare decisions and policy. They may serve to improve quality of treatment, and shorten the time frame between the development and widespread dissemination of effective methods, thereby reducing health cost expenditure.The results of this study will not only inform about the degree to which the new methods lead to an improvement of treatment course and outcome, but also about whether the effects of routine psychotherapeutic treatment are comparable to those of the controlled, strictly manualized treatments of the SOPHO-NET study.

Trial registration: ClinicalTrials.gov identifier: NCT01388231. This study was funded by the German Federal Ministry of Education and Research (SOPHO-NET: BMBF 01GV0607; SOPHO-PRAX: BMBF 01GV1001).

Figures

Figure 1
Figure 1
Intervention scheme/trial flow.
Figure 2
Figure 2
Time points of assessment. 1) LSAS self rating, 2) LSAS observer rating.

References

    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR Fourth Edition (Text Revision) Washington: APA; 2000.
    1. Fehm L, Beesdo K, Jacobi F, Fiedler A. Social anxiety disorder above and below the diagnostic threshold: prevalence, comorbidity and impairment in the general population. Soc Psychiatry Psychiatr Epidemiol. 2008;43:257–265. doi: 10.1007/s00127-007-0299-4.
    1. Ruscio AM, Brown TA, Chiu WT, Sareen J, Stein MB, Kessler RC. Social fears and social phobia in the United States: results from the National Comorbidity Survey Replication. Psychol Med. 2008;38:15–28.
    1. Fehm L, Pelissolo A, Furmark T, Wittchen H-U. Size and burden of social phobia in Europe. Eur Neuropsychopharmacol. 2005;15:453–462. doi: 10.1016/j.euroneuro.2005.04.002.
    1. Wittchen HU, Jacobi F. Die Versorgungssituation psychischer Störungen in Deutschland. Eine klinisch-epidemiologische Abschätzung anhand des Bundes-Gesundheitssurveys 1998. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz. 2001;44:993–1000. doi: 10.1007/s001030100269.
    1. Wittchen HU, Fehm L. Epidemiology and natural course of social fears and social phobia. Acta Psychiatr Scand. 2003;108(Suppl 1):4–18.
    1. Beesdo K, Bittner A, Pine DS, Stein MB, Höfler M, Lieb R, Wittchen H-U. Incidence of social anxiety disorder and the consistent risk for secondary depression in the first three decades of life. Arch Gen Psychiatry. 2007;64:903–912. doi: 10.1001/archpsyc.64.8.903.
    1. DeWit DJ, Ogborne A, Offord DR, McDonald K. Antecedents of the risk of recovery from DSM-III social phobia. Psychol Med. 1999;29:569–582. doi: 10.1017/S0033291799008399.
    1. Keller MB. The lifelong course of social anxiety disorder: a clinical perspective. Acta Psychiatr Scand. 2003;108(Suppl 1):85–94.
    1. Yonkers KA, Dyck IR, Keller MB. An eight-year longitudinal comparison of clinical course and characteristics of social phobia among men and women. Psychiatr Serv. 2001;52:637–643. doi: 10.1176/appi.ps.52.5.637.
    1. Beidel DC, Turner SM, Dancu CV. Physiological, cognitive, and behavioral aspects of social anxiety. Behav Res Ther. 1985;23:109–117. doi: 10.1016/0005-7967(85)90019-1.
    1. Heimberg RG, Hope DA, Dodge CS, Becker RE. DSM-III-R subtypes of social phobia: comparison of generalized social phobics and public speaking phobics. J Nerv Ment Dis. 1990;178:172–179. doi: 10.1097/00005053-199003000-00004.
    1. Herbert JD, Hope DA, Bellack AS. Validity of the distinction between generalized social phobia and avoidant personality disorder. J Abnorm Psychol. 1992;101:332–339.
    1. Ludwig R, Lazarus P. Relationship between shyness in children and constricted cognitive control as measured by the Stroop Color-Word Test. J Consult Clin Psych. 1983;51:386–389.
    1. Powers MB, Sigmarsson SR, Emmelkamp PMP. A meta-analytic review of psychological treatments for social anxiety disorder. Int J Cogn Ther. 2008;1:94–113. doi: 10.1521/ijct.2008.1.2.94.
    1. Acarturk C, Cujpers P, van Straten A, de Graaf R. Psychological treatment of social anxiety disorder: a meta-analysis. Psychol Med. 2009;39:241–254. doi: 10.1017/S0033291708003590.
    1. Clark D, Wells A. In: In Social phobia: Diagnosis, assessment, and treatment. Heimberg R, Liebowitz M, Hope D, Schneier F, editor. New York: Guilford; 1995. A cognitive model of social phobia; pp. 69–93.
    1. Clark DM, Ehlers A, McManus F, Hackmann A, Fennell M, Campbell H, Flower T, Davenport C, Louis B. Cognitive therapy versus Fluoxetine in generalized social phobia: a randomized placebo-controlled trial. J Consult Clin Psych. 2003;71:1058–1067.
    1. Clark DM, Ehlers A, Hackman A, McManus F, Fennell M. Cognitive therapy versus exposure and applied relaxation in Social Phobia: a randomized controlled trial. J Consult Clin Psych. 2006;74:568–578.
    1. Barlow DH. The dissemination and implementation of evidence-based psychological treatments – a review of current efforts. Am Psychol. 2004;59:869–878.
    1. Leichsenring F, Hoyer J, Beutel M, Herpertz S, Hiller W, Irle E, Joraschky P, König HH, de Liz TM, Nolting B, Pöhlmann K, Salzer S, Schauenburg H, Stangier U, Strauss B, Subic-Wrana C, Vormfelde S, Weniger G, Willutzki U, Wiltink J, Leibing E. The Social Phobia Psychotherapy Research Network. The first multicenter randomized controlled trial of psychotherapy for social phobia: rationale, methods and patient characteristics. Psychother Psychosomat. 2009;78:35–41. doi: 10.1159/000162299.
    1. Stangier U. Clark DM, Ehlers A: Soziale Phobie. Hogrefe, Göttingen; 2006.
    1. Stangier U, Ehlers A. Clark DM: Soziale Phobie. Hogrefe, Fortschritte der Psychotherapie. Göttingen; 2006.
    1. Stangier U, Heidenreich T, Stangier U, Heidenreich T. Internationale Skalen für Psychiatrie. 5 2005. Liebowitz Soziale Angst Skala.
    1. Fydrich T. Soziale Phobie und Angstinventar (SPAI). Deutschsprachige Adaptation des "Social Phobia and Anxiety Inventory" von Turner und Beidel. Hogrefe, Göttingen; 2003.
    1. Stangier U, Heidenreich T, Peitz M. Soziale Phobien. Weinheim: Beltz, Ein kognitiv-verhaltenstherapeutisches Behandlungsmanual; 2003.
    1. Stangier U, Heidenreich T, Schermelleh-Engel K. Safety behaviors and social performance in patients with generalized social phobia. J CogPsychother. 2006;20:417–431.
    1. Davidson JR, Potts NL, Richichi EA, Ford SM, Krishnan KR, Smith RD, Wilson W. The brief social phobia scale. J Clin Psychiat. 1991;52(Suppl 1):48–51.
    1. Hautzinger M, Bailer M, Worall H. Keller, F: Das Beck Depressionsinventar. Bern: Huber; 1995.
    1. von der Schulenburg JM G, Claes C, Greiner W, Uber A. Die deutsche Version des EuroQol-Fragebogens. Zeitschrift für Gesundheitswissenschaften. 1998;6:3–20.
    1. Hoffmann SG, Kashdan B. The affective style questionnaire: development and psychometric properties. J Psychopathol Behav. 2009;32:255–263.
    1. Bassler M, Potratz B, Krauthauser H. Der "Helping Alliance Questionaire" (HAQ) von Luborsky. Möglichkeiten zur Evaluation des therapeutischen Prozesses von stationärer Psychotherapie. Psychotherapeut. 1995;40:23–32.
    1. Krampen G. Stundenbogen für die Allgemeine und Differentielle Einzelpsychotherapie. Göttingen: Hogrefe; 2002.
    1. Borkovec TD, Nau SD. Credibility of analogue therapy rationales. J Behav Ther Exp Psy. 1972;3:257–260. doi: 10.1016/0005-7916(72)90045-6.
    1. Holt CS, Heimberg RG. The reaction to treatment questionnaire: measuring treatment credibility and outcome expectancies. The Behavior Therapist. 1990;13:213–214.
    1. Zaider TI, Heimberg RG, Fresco DM, Schneier FR, Liebowitz MR. Evaluation of the clinical global impression scale among individuals with social anxiety disorder. Psychol Med. 2003;33:611–622. doi: 10.1017/S0033291703007414.
    1. Wiltink J, Ruckes C, Haselbacher A, Canterino M, Leichsenring F, Joraschky P, Leweke F, Pöhlmann K, Beutel ME. Transfer of manualized Short Term Psychodynamic Psychotherapy (STPP) for social phobia into clinical practice: study protocol for a cluster-randomised controlled trial. Trials. 2011;12:142. doi: 10.1186/1745-6215-12-142.
    1. Roick C, Kilian R, Matschinger H, Bernert S, Mory C, Angermeyer MC. German adaptation of the client sociodemographic and service receipt inventory - an instrument for the cost of mental health care. Psychiatr Prax. 2001;28(Suppl 2):84–90.
    1. Sholomskas DE, Syracuse-Siewert G, Rounsaville BJ, Ball SA, Nuro KF, Carroll KM. We don’t train in vain: A dissemination trial of three strategies of training clinicians in cognitive-behavioral therapy. J Consult Clin Psych. 2005;73:106–115.
    1. Campbell MJ, Mollison J, Grimshaw JM. Cluster trials in implementation research: estimation of intracluster correlation coefficients and sample size. Stat Med. 2001;20:391–399. doi: 10.1002/1097-0258(20010215)20:3<391::AID-SIM800>;2-Z.
    1. Campbell MJ, Elbourne DR, Altman DG. CONSORT statement: extension to cluster randomised trials. BMJ. 2004;238:702–708.
    1. Donner A, Klar N. Design and Analysis of Cluster Randomization Trials in Health Research. London: Arnold; 2000.
    1. Stangier US, Heidenreich T, Peitz M, Lauterbach W, Clark DM. Cognitive therapy for social phobia: individual versus group treatment. Behav Res Ther. 2003;41:991–1007. doi: 10.1016/S0005-7967(02)00176-6.
    1. Elashoff JD. nQuery Advisor. Version 6.01 User’s Guide. Los Angeles, CA; 2005.
    1. Stangier US, Schramm E, Heidenreich T, Berger M, Clark DM. Cognitive therapy vs interpersonal psychotherapy in social anxiety disorder - a randomized controlled trial. Arch Gen Psychiatry. 2011;68:692–700. doi: 10.1001/archgenpsychiatry.2011.67.
    1. Wood AM, White IR, Hillson M, Carpenter J. Comparison of imputation and modelling methods in the analysis of a physical activity trial with missing outcomes. Int J Epidemiol. 2005;34:89–99.
    1. Campbell MK, Mollison J, Steen N, Grimshaw JM, Eccles M. Analysis of cluster randomized trials in primary care: a practical approach. Fam Pract. 2000;17:192–196. doi: 10.1093/fampra/17.2.192.
    1. Gaston JE, Abbott MJ, Rapee RM, Neary SA. Do empirically supported treatments generalize to private practice? A benchmark study of a cognitive-behavioural group treatment programme for social phobia. Br J Clin Psychol. 2006;45:33–48. doi: 10.1348/014466505X35146.
    1. Dimeff LA, Koerner K, Woodcock EA, Beadnell B, Brown MZ, Skutch JM, Paves AP, Bazinet A, Harned MS. Which training method works best? A randomized controlled trial comparing three methods of training clinicians in dialectical behavior therapy skills. Behav Res Ther. 2009;47:921–930. doi: 10.1016/j.brat.2009.07.011.
    1. Thoma NC, McKay D, Gerber AJ, Milrod BL, Edwards AR, Kocsis JH. A quality-based review of randomized controlled trials of cognitive-behavioral therapy for depression: an assessment and metaregression. Am J Psychiatry. 2012;169:22–30.
    1. Ost LG. Cognitive behavior therapy for anxiety disorders: 40 years of progress. Nord J Psychiatry. 2008;62(Suppl 1):5–10.
    1. Shafran R, Clark DM, Fairburn CG, Arntz A, Barlow DH, Ehlers A, Freeston M, Garety PA, Hollon SD, Ost LG, Salkovskis PM, Williams JMG, Wilson GT. Mind the gap: Improving the dissemination of CBT. BRAT. 2009;47:902–909.
    1. Beutel ME, Rasting M, Stuhr U, Rüger B, Leuzinger-Bohleber M. Assessing the impact of psychoanalyses and long-term psychoanalytic therapies on health care utilization and costs. Psychother Res. 2004;14:146–160. doi: 10.1093/ptr/kph014.
    1. Christensen E. Methodology of superiority vs. equivalence trials and non-inferiority trials. J Hepatol. 2007;46:947–954.
    1. Bland JM, Altman DG. One and two sided tests of significance. BMJ. 1994;309:248. doi: 10.1136/bmj.309.6949.248.
    1. Knottnerus JA, Bouter LM. The ethics of sample size: Two-sided testing and one-sided thinking. J ClinEpidemiol. 2001;54:109–111.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren